Dexmedetomidine attenuates repeated propofol exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling disruption, and juvenile cognitive deficits in neonatal rats

Wang,Yujie; Wu,Changyi; Han,Bin; Xu,Fei; Mao,Mingfeng; Guo,Xiangyang; Wang,Jun

doi:10.3892/mmr.2016.5321

Dexmedetomidine attenuates repeated propofol exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling disruption, and juvenile cognitive deficits in neonatal rats

Authors:
- Yujie Wang
- Changyi Wu
- Bin Han
- Fei Xu
- Mingfeng Mao
- Xiangyang Guo
- Jun Wang
View Affiliations

Affiliations: Department of Anesthesiology, Peking University Third Hospital, Beijing 100191, P.R. China, Department of Otolaryngology, 316 Hospital of People's Liberation Army, Beijing 100093, P.R. China
Published online on: May 23, 2016 https://doi.org/10.3892/mmr.2016.5321
Pages: 769-775
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Propofol is one of the most widely used intravenous anesthetics. However, repeated exposure to propofol may cause neurodegeneration in the developing brain. Dexmedetomidine (Dex), an α2 adrenoceptor agonist, has been previously demonstrated to provide neuroprotection against neuroapoptosis and neurocognitive impairments induced by several anesthetics. Thus, the current study aimed to investigate the effect of Dex on neonatal propofol-induced neuroapoptosis and juvenile spatial learning/memory deficits. Propofol (30 mg/kg) was intraperiotoneally administered to 7‑day‑old Sprague Dawley rats (n=75) three times each day at 90 min intervals for seven consecutive days with or without Dex (75 µg/kg) treatment 20 min prior to propofol injection. Following repeated propofol exposure, reduced Akt and GSK‑3β phosphorylation, increased cleaved caspase‑3 expression levels, an increased Bax/Bcl‑2 ratio, and increased terminal deoxynucleotidyl transferase‑mediated dUTP nick‑end labeling (TUNEL)‑positive cells in the CA1 hippocampal subregion were observed. Morris Water Maze testing at postnatal day 29 also demonstrated spatial learning and memory deficits following propofol treatment compared with the control group. Notably, these changes were significantly attenuated by Dex pretreatment. The results of the current study demonstrated that Dex ameliorates the neurocognitive impairment induced by repeated neonatal propofol challenge in rats, partially via its anti‑apoptotic action and normalization of the disruption to the PI3K/Akt/GSK‑3β signaling pathway. The present study provides preliminary evidence demonstrating the safety of propofol on the neonatal brain and the potential use of dexmedetomidine pretreatment in pediatric patients.

View Figures

View References

1	Sun LS, Li G, DiMaggio CJ, Byrne MW, Ing C, Miller TL, Bellinger DC, Han S and McGowan FX: Feasibility and pilot study of the Pediatric Anesthesia NeuroDevelopment Assessment (PANDA) project. J Neurosurg Anesthesiol. 24:382–388. 2012. View Article : Google Scholar : PubMed/NCBI
2	Zhu C, Gao J, Karlsson N, Li Q, Zhang Y, Huang Z, Li H, Kuhn HG and Blomgren K: Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents. J Cereb Blood Flow Metab. 30:1017–1030. 2010. View Article : Google Scholar : PubMed/NCBI
3	Sun L: Early childhood general anaesthesia exposure and neurocognitive development. Br J Anaesth. 105(Suppl 1): pp. i61–i68. 2010, View Article : Google Scholar
4	Wilder RT, Flick RP, Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL and Warner DO: Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology. 110:796–804. 2009. View Article : Google Scholar : PubMed/NCBI
5	Kay B and Rolly G: I.C.I. 35868, a new intravenous induction agent. Acta Anaesthesiol Belg. 28:303–316. 1977.PubMed/NCBI
6	Harman F, Hasturk AE, Yaman M, Arca T, Kilinc K, Sargon MF and Kaptanoglu E: Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model. Childs Nerv Syst. 28:1055–1062. 2012. View Article : Google Scholar : PubMed/NCBI
7	Rossaint J, Rossaint R, Weis J, Fries M, Rex S and Coburn M: Propofol: Neuroprotection in an in vitro model of traumatic brain injury. Crit Care. 13:R612009. View Article : Google Scholar : PubMed/NCBI
8	Creeley C, Dikranian K, Dissen G, Martin L, Olney J and Brambrink A: Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br J Anaesth. 110(Suppl 1): i29–i38. 2013. View Article : Google Scholar : PubMed/NCBI
9	Krzisch M, Sultan S, Sandell J, Demeter K, Vutskits L and Toni N: Propofol anesthesia impairs the maturation and survival of adult-born hippocampal neurons. Anesthesiology. 118:602–610. 2013. View Article : Google Scholar : PubMed/NCBI
10	Sanchez V, Feinstein SD, Lunardi N, Joksovic PM, Boscolo A, Todorovic SM and Jevtovic-Todorovic V: General anesthesia causes long-term impairment of mitochondrial morphogenesis and synaptic transmission in developing rat brain. Anesthesiology. 115:992–1002. 2011. View Article : Google Scholar : PubMed/NCBI
11	Cantley LC: The phosphoinositide 3-kinase pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
12	Gray JJ, Bickler PE, Fahlman CS, Zhan X and Schuyler JA: Isoflurane neuroprotection in hypoxic hippocampal slice cultures involves increases in intracellular Ca2+ and mitogen-activated protein kinases. Anesthesiology. 102:606–615. 2005. View Article : Google Scholar : PubMed/NCBI
13	Dewachter I, Ris L, Jaworski T, Seymour CM, Kremer A, Borghgraef P, De Vijver H, Godaux E and Van Leuven F: GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9. Neurobiol Dis. 35:193–200. 2009. View Article : Google Scholar : PubMed/NCBI
14	Hsing CH, Chen YH, Chen CL, Huang WC, Lin MC, Tseng PC, Wang CY, Tsai CC, Choi PC and Lin CF: Anesthetic propofol causes glycogen synthase kinase-3β-regulated lysosomal/mitochondrial apoptosis in macrophages. Anesthesiology. 116:868–881. 2012. View Article : Google Scholar : PubMed/NCBI
15	Duan X, Li Y, Zhou C, Huang L and Dong Z: Dexmedetomidine provides neuroprotection: Impact on ketamine-induced neuroapoptosis in the developing rat brain. Acta Anaesthesiol Scand. 58:1121–1126. 2014. View Article : Google Scholar : PubMed/NCBI
16	Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, Sun P, Hossain M, Ma D and Maze M: Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 110:1077–1085. 2009. View Article : Google Scholar : PubMed/NCBI
17	Wang Z, Kou D, Li Z, He Y, Yu W and Du H: Effects of propofol-dexmedetomidine combination on ischemia reperfusion-induced cerebral injury. Neuro Rehabilitation. 35:825–834. 2014.PubMed/NCBI
18	Degos V, Charpentier TL, Chhor V, Brissaud O, Lebon S, Schwendimann L, Bednareck N, Passemard S, Mantz J and Gressens P: Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Anesthesiology. 118:1123–1132. 2013. View Article : Google Scholar : PubMed/NCBI
19	Li Y, Zeng M, Chen W, Liu C, Wang F, Han X, Zuo Z and Peng S: Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats. PLoS One. 9:e936392014. View Article : Google Scholar : PubMed/NCBI
20	Li ZQ, Rong XY, Liu YJ, Ni C, Tian XS, Mo N, Chui DH and Guo XY: Activation of the canonical nuclear factor-κB pathway is involved in isoflurane-induced hippocampal interleukin-1β elevation and the resultant cognitive deficits in aged rats. Biochem Biophys Res Commun. 438:628–634. 2013. View Article : Google Scholar : PubMed/NCBI
21	Liang Y, Li Z, Mo N, Li M, Zhuang Z, Wang J, Wang Y and Guo X: Isoflurane preconditioning ameliorates renal ischemia-reperfusion injury through antiinflammatory and anti-apoptotic actions in rats. Biol Pharm Bull. 37:1599–1605. 2014. View Article : Google Scholar
22	Kawaguchi M, Furuya H and Patel PM: Neuroprotective effects of anesthetic agents. J Anesth. 19:150–156. 2005. View Article : Google Scholar : PubMed/NCBI
23	Zhou Z and Ma D: Anaesthetics-induced neurotoxicity in developing brain: An update on preclinical evidence. Brain Sci. 4:136–149. 2014. View Article : Google Scholar : PubMed/NCBI
24	Gao J, Peng S, Xiang S, Huang J and Chen P: Repeated exposure to propofol impairs spatial learning, inhibits LTP and reduces CaMKIIα in young rats. Neurosci Lett. 560:62–66. 2014. View Article : Google Scholar
25	Pesić V, Milanović D, Tanić N, Popić J, Kanazir S, Jevtović-Todorović V and Ruzdijić S: Potential mechanism of cell death in the developing rat brain induced by propofol anesthesia. Int J Dev Neurosci. 27:279–287. 2009. View Article : Google Scholar
26	Bercker S, Bert B, Bittigau P, Felderhoff-Müser U, Bührer C, Ikonomidou C, Weise M, Kaisers UX and Kerner T: Neurode-generation in newborn rats following propofol and sevoflurane anesthesia. Neurotox Res. 16:140–147. 2009. View Article : Google Scholar : PubMed/NCBI
27	Engelhard K, Werner C, Eberspächer E, Bachl M, Blobner M, Hildt E, Hutzler P and Kochs E: The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S (+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 96:524–531. 2003.
28	Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP and Maze M: Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol. 502:87–97. 2004. View Article : Google Scholar : PubMed/NCBI
29	Zhu YM, Wang CC, Chen L, Qian LB, Ma LL, Yu J, Zhu MH, Wen CY, Yu LN and Yan M: Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res. 1494:1–8. 2013. View Article : Google Scholar
30	Wang H, Luo QF, Peng AF, Long XH, Wang TF, Liu ZL, Zhang GM, Zhou RP, Gao S, Zhou Y and Chen WZ: Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma. Int J Mol Med. 33:633–639. 2014.
31	Leroy K and Brion JP: Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat. 16:279–293. 1999. View Article : Google Scholar : PubMed/NCBI
32	Yuskaitis CJ and Jope RS: Glycogen synthase kinase-3 regulates microglial migration, inflammation and inflammation-induced neurotoxicity. Cell Signal. 21:264–273. 2009. View Article : Google Scholar
33	Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML and Heidenreich KA: Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci. 24:9993–10002. 2004. View Article : Google Scholar : PubMed/NCBI
34	Zhao YL, Xiang Q, Shi QY, Li SY, Tan L, Wang JT, Jin XG and Luo AL: GABAergic excitotoxicity injury of the immature hippocampal pyramidal neurons' exposure to isoflurane. Anesth Analg. 113:1152–1160. 2011. View Article : Google Scholar : PubMed/NCBI
35	Sinner B, Friedrich O, Zink W, Zausig Y and Graf BM: The toxic effects of s (+)-ketamine on differentiating neurons in vitro as a consequence of suppressed neuronal Ca2+ oscillations. Anesth Analg. 113:1161–1169. 2011. View Article : Google Scholar : PubMed/NCBI
36	Wei H and Inan S: Dual effects of neuroprotection and neurotoxicity by general anesthetics: Role of intracellular calcium homeostasis. Prog Neuropsychopharmacol Biol Psychiatry. 47:156–161. 2013. View Article : Google Scholar : PubMed/NCBI
37	Chen Y, Zhao Z, Code WE and Hertz L: A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes. Anesth Analg. 91:353–357. 2000.PubMed/NCBI
38	Liao Z, Cao D, Han X, Liu C, Peng J, Zuo Z, Wang F and Li Y: Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats. Brain Res Bull. 107:69–78. 2014. View Article : Google Scholar : PubMed/NCBI